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The effect of the carbimazole on expression of tumor necrosis factor (TNF-α) in liver, was investigated in an
experimental model of high fat diet (HFD) induced obesity. The HFD (orally given for 4 months) induced
TNF-α in liver tissue along with raised serum triglyceride (TG), cholesterol and high TSH (62%). In carbimazole
(1 mg/100 gbw) treatment, the induction of TNF-α was significantly inhibited, without affecting other parameters.
It also improved the liver function, which was raised due to HFD in experimental control rats.
Keywords: Obesity, High fat diet, Carbimazole, TNF-αIntroduction
The inflammation is the primary cause of metabolic
syndrome [MS] [1]. It is associated with faulty life style
and food habits [2] and results to ectopic fat deposition
[3]. The involvement of adipogenesis and high TSH has
been reported [4,5]. The raised inflamation is due to
accumulation of M-1 macrophages [6]. Whether this
induction is a cause or effect of obesity is debatable. Simi-
lar to pre-diabetic patient with impaired glucose tolerance
(IGT), where both insulin and glucose levels are higher,
[7,8] raised TSH may be adaptive as reported by others
also [9]. Here we have investigated role of Carbimazole on
high fat diet induced expression of inflammatory markers
and tried to correlate the inter relationship between obes-
ity, thyroid function and inflammation.Material and methods
The rats were divided into group-1 (maintained normal
diet and water). Group −2 [received high fat diet (HFD)
(lard [400 g/lit], 20% fructose, casein [80 g/lit], choles-
terol] Group- 3 [received HFD + Carbimazole (Abbott,
HP, India) (1 mg/100 gbw)]. Above treatments were
continued for 4 months and finally rats were sacrificed
to assess lipid profile (serum triglyceride (TG) and choles-
terol) and liver function test namely aminotransferase
(AST), Alanine transaminase (ALT), and alkaline* Correspondence: yaminiok@yahoo.com
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article, unless otherwise stated.phosphatase (ALKP) and thyroid stimulating hormone
(TSH). The expression of TNF-alpha was determined
in Liver tissue by RT-PCR [10].
Ethical clearance: The protocol was approved by animal
ethics committee of our Institution (IMS, BHU-letter #
Dean/2005-06/Animal Ethical Committee/390 dated-
18.05.2006).
Results
Lipid profile, liver function and TSH were significantly
raised in animals fed with HFD (Table 1). There was
high expression of TNF-α (Figure 1) also in these rats.
In Carbimazole treated animals (group 2) there was
significant prevention in rise of liver function enzymes
and TNF-α, without significant change in serum TG,
cholesterol and TSH.
Discussion
It is well documented that faulty diet and life style medi-
ated physiological changes induces systemic low grade
inflammation [LGI]. Our results indicate the raised
serum TSH and TNF-α in high fat diet fed rats and
lower in carbimazole treated rats (when compared to
normal control animals of Gr-1). This could be due to
inhibitory action of carbimazole on Rac1, involved in ex-
pression of TNF-α [11]. Since, TSH level remains same
as in experimental control (only HFD rats), there could
direct inhibitory effect of TSH on expression of TNF-α
as reported earlier in case of osteoclast [12]. High release
of Leptin by adipocytes is reported in obesity, whichCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Blood biochemistry after 4 months of various treatments
Diet type Normal HFD (experimental control) HFD + Carbimazole
Body weight [g] 165 ± 7.0 162.5 ± 37.5 167 ± 22.1
Triglycerides [mg/dl] 85.8 ± 9.3 115.6 ± 33 124 ± 45
Cholesterol [mg/dl] 72.5 ± 10.2 110 ± 45 96.9 ± 13.6
AST [U/L] 72.5 ± 10.2 126.6 ± 9.9 113.1 ± 12.3*
ALT [U/L] 72.2 ± 10.2 105.9 ± 3.2 92.9 ± 5.73*
ALP [U/L] 441.8 ± 8.2 361.2 ± 30.8 373.5 ± 18.8
TSH [μU/ml] 0.3 ± 0.024 0.8 ± .040 0.7 ± .032
Data presented as mean ± SD. P value: (N = 6), *< 0.05 when compared experimental control with carbimazole treated rat.
Figure 1 RT-PCR assessment of TNF-α [4 months] photograph normalized with GAPDH. A: rats with high fat diet (HFD) B: Rats with HFD +
Carbimazole, C: normal rats, D: 200 bp DNA ladder.
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Gr 2 and Gr3 animals could an adaptive mechanism to re-
duce circulating free fatty acid, as it is involved in insulin
resistance and systemic inflammation. Thus it could be
considered as protective mechanism. The raised TSH in
obesity further enhances the release of T3 and T4, respon-
sible for rise in thermogenesis and reduction of deposited
lipid [13]. Thus low T3 and T4 in established obesity
could be an indication of failure of system in counteract-
ing the obesity. Many reports suggest that hypothyroidism
could be the cause for obesity. Diez et al. have reported
TNF –α mediated destruction of thyroid cells, resulting to
low T3/T4 and raised TSH [14]. It is associated with accu-
mulation of adipose-tissue-embedded macrophages in
obesity. Higher Leptin in obese, is another factor to in-
crease TSH. Contrary to this, raised TSH inhibits se-
cretion of TNF–α in some cells like osteoclast [12]. This
may happen in other tissue also where TSH receptor
are reported. Thus, hypothyroid condition in obesity could
be an initial step to regulate the abnormal physiology, but
it needs further experimental evidences.
Conclusion
The inhibition of TNF –α expression in carbimazole
treated group could be its direct anti-inflammatoryeffect, but it can also be through high TSH, which needs
further exploration.
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